BetterLife Pharma Stock

BetterLife Pharma EBIT Margin

EBIT Margin (Operating Margin) of BetterLife Pharma (BETR.CN) as of Aug 14, 2026.

EBIT Margin

0.00

Last updated:

EBIT Margin (Operating Margin) of BetterLife Pharma is 2026 0.00 . EBIT Margin (Operating Margin) of BetterLife Pharma was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

BetterLife Pharma Stock analysis

What does BetterLife Pharma do? BetterLife Pharma Inc is an innovative company specializing in the development and marketing of therapeutic solutions. The company was founded in 2016 and is headquartered in Vancouver, Canada. It is a publicly traded company listed on the Canadian stock exchange TSX Venture Exchange under the ticker symbol BETR and on the Frankfurt stock exchange under the ticker symbol NPA. BetterLife's mission is to research and develop life-changing medications that improve patients' lives while increasing shareholder value. The company relies on a combination of scientific knowledge and innovative technology to develop effective and safe therapies. BetterLife Pharma is divided into the biotechnology and healthcare sectors. In biotechnology research, the company focuses on developing novel medications for the treatment of conditions such as depression, anxiety, pain, and autoimmune diseases. In healthcare, the company offers a range of services including clinical trials and consulting for healthcare organizations and companies. An important product of BetterLife is the medication TD-0148A, which is developed for the treatment of depression. It aims to regulate neurotransmitters in the brain to improve the mood of depressive patients. The medication is currently in clinical phase II and has the potential to be used by millions of patients worldwide. Another important product of BetterLife is the platform technology Cyclica, which allows companies and researchers to make better predictions about drug effects. Cyclica utilizes artificial intelligence and machine learning to gather and analyze a wide range of information about drugs and their mechanisms of action. The technology has already gained global recognition and is used by prestigious institutions such as Harvard Medical School. BetterLife's business model is based on collaboration with other companies, researchers, and healthcare experts. The company aims to form partnerships with companies in the biotech and pharmaceutical industries to further develop and market its technologies and products. In recent years, BetterLife Pharma Inc has made significant progress and achieved impressive milestones. The company has conducted several successful financing rounds to fund its research and development. It has formed strategic alliances with key players in the industry and promoted its technologies and products worldwide. BetterLife Pharma represents innovation, excellence, and excellence in research and development. The company has the potential to improve the lives of millions of people worldwide while providing attractive returns for its investors. BetterLife Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BetterLife Pharma stock

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) BetterLife Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s BetterLife Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — BetterLife Pharma

All Key Metrics — BetterLife Pharma